HIV molecular immunology database
Found 7 matching records:
HXB2 Location | Gag(22-30) | Gag Epitope Map
View variants at this location |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
RPGGKKHYM
|
Epitope Alignment | ||||||||||
Variants |
|
|||||||||||
Epitope Name | p17-RM9 | |||||||||||
Species (MHC/HLA) | human(B*42:01, B*42:02) |
Showing all: 3 variant(s).
Variant ID. | 3110 |
---|---|
Epitope Seq. | RPGGKKHYM |
Variant Seq. | RPGGKKrYM |
Mutations | H/R |
Epitope Location | H7R |
HXB2 Location | H28R |
Mutation Type | E: escape documented in this paper |
Epitope Subtype | C |
Variant Subtype | C |
Method | CD8 T-cell Elispot - IFNy, HLA binding, Sequence |
Note | p17-RM9 mutation, RPGGKKrYM, is selected in 13% HLA-B*4201 (8% have wt RM9), 10% HLA-B*4202 (31% have wt RM9) and 8% on-HLA-B*42 (46% have wt RM9) subjects. The authors designate this variant as an escape when presented by HLAs-B*4201 and -B*4202. |
Variant ID. | 3111 |
---|---|
Epitope Seq. | RPGGKKHYM |
Variant Seq. | RPGGKKHYk |
Mutations | M/K |
Epitope Location | M9K |
HXB2 Location | M30K |
Mutation Type | OV: observed variant |
Epitope Subtype | C |
Variant Subtype | C |
Method | CD8 T-cell Elispot - IFNy, HLA binding, Sequence |
Note | p17-RM9 mutation, RPGGKKHYk, is selected in 9% HLA-B*4201 (8% have wt RM9), 5% HLA-B*4202 (31% have wt RM9) and 2% on-HLA-B*42 (46% have wt RM9) subjects. |
Variant ID. | 3112 |
---|---|
Epitope Seq. | RPGGKKHYM |
Variant Seq. | RPGGKKHYr |
Mutations | M/R |
Epitope Location | M9R |
HXB2 Location | M30R |
Mutation Type | OV: observed variant |
Epitope Subtype | C |
Variant Subtype | C |
Method | CD8 T-cell Elispot - IFNy, HLA binding, Sequence |
Note | p17-RM9 mutation, RPGGKKHYr, is selected in 4% HLA-B*4201 (8% have wt RM9), 0% HLA-B*4202 (31% have wt RM9) and 1% on-HLA-B*42 (46% have wt RM9) subjects. |
Kloverpris2012a Henrik N. Kløverpris, Mikkel Harndahl, Alasdair J. Leslie, Jonathan M. Carlson, Nasreen Ismail, Mary van der Stok, Kuan-Hsiang Gary Huang, Fabian Chen, Lynn Riddell, Dewald Steyn, Dominique Goedhals, Cloete van Vuuren, John Frater, Bruce D. Walker, Mary Carrington, Thumbi Ndung'u, Søren Buus, and Philip Goulder. HIV Control through a Single Nucleotide on the HLA-B Locus. J. Virol., 86(21):11493-11500, Nov 2012. PubMed ID: 22896606. Show all entries for this paper.
HXB2 Location | Gag(180-188) | Gag Epitope Map
View variants at this location |
||||
---|---|---|---|---|---|---|
Epitope |
TPQDLNTML
|
Epitope Alignment | ||||
Variants |
|
|||||
Epitope Name | Gag-TL9 | |||||
Species (MHC/HLA) | human(B*42:01) |
Showing all: 1 variant(s).
Variant ID. | 3113 |
---|---|
Epitope Seq. | TPQDLNTML |
Variant Seq. | TPxDLNTML |
Mutations | Q/X |
Epitope Location | Q3X |
HXB2 Location | Q182X |
Mutation Type | E: escape documented in this paper |
Epitope Subtype | C |
Variant Subtype | C |
Method | CD8 T-cell Elispot - IFNy, HLA binding, Sequence |
Note | p24-TL9 mutation, TPxDLNTML, is selected in 21% HLA-B*4201 (75% have wt TL9), 15% HLA-B*4202 (82% have wt TL9) and 5% HLA-B*42-negative (89% have wt TL9) subjects. Mutant TPlDLNTML is designated as an escape by the authors when presented by HLA-B*4201. |
Kloverpris2012a Henrik N. Kløverpris, Mikkel Harndahl, Alasdair J. Leslie, Jonathan M. Carlson, Nasreen Ismail, Mary van der Stok, Kuan-Hsiang Gary Huang, Fabian Chen, Lynn Riddell, Dewald Steyn, Dominique Goedhals, Cloete van Vuuren, John Frater, Bruce D. Walker, Mary Carrington, Thumbi Ndung'u, Søren Buus, and Philip Goulder. HIV Control through a Single Nucleotide on the HLA-B Locus. J. Virol., 86(21):11493-11500, Nov 2012. PubMed ID: 22896606. Show all entries for this paper.
HXB2 Location | Pol(426-434) | Pol Epitope Map
View variants at this location |
|||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
YPGIKVRQL
|
Epitope Alignment | |||||||||||||||||||||||||
Variants |
|
||||||||||||||||||||||||||
Epitope Name | RT-YL9 | ||||||||||||||||||||||||||
Species (MHC/HLA) | human(B*42:01, B*42:02) |
Showing all: 8 variant(s).
Variant ID. | 3119 |
---|---|
Epitope Seq. | YPGIKVRQL |
Variant Seq. | YaGIKVRQL |
Mutations | P/A |
Epitope Location | P2A |
HXB2 Location | P427A |
Mutation Type | E: escape documented in this paper |
Epitope Subtype | C |
Variant Subtype | C |
Method | Sequence |
Note | RT-YL9 mutation, YaGIKVRQL, is selected in 20% HLA-B*4201 (4% have wt YL9) subjects. The authors designate mutant YaGIKVRQL as an escape when presented by HLA-B*4201. |
Variant ID. | 3120 |
---|---|
Epitope Seq. | YPGIKVRQL |
Variant Seq. | YPGIrVRQL |
Mutations | K/R |
Epitope Location | K5R |
HXB2 Location | K430R |
Mutation Type | OV: observed variant |
Epitope Subtype | C |
Variant Subtype | C |
Method | Sequence |
Note | RT-YL9 mutation, YPGIrVRQL, is selected in 14% HLA-B*4202 (0% have wt YL9) subjects. |
Variant ID. | 3121 |
---|---|
Epitope Seq. | YPGIKVRQL |
Variant Seq. | YPGIKVRgL |
Mutations | Q/G |
Epitope Location | Q8G |
HXB2 Location | Q433G |
Mutation Type | E: escape documented in this paper |
Epitope Subtype | C |
Variant Subtype | C |
Method | Sequence |
Note | RT-YL9 mutation, YPGIKVRgL, is selected in 14% HLA-B*4202 (0% have wt YL9) subjects. The authors designate mutant YPGIKVRgL as an escape when presented by HLA-B*4202. |
Variant ID. | 3122 |
---|---|
Epitope Seq. | YPGIKVRQL |
Variant Seq. | YPGIKVRrL |
Mutations | Q/R |
Epitope Location | Q8R |
HXB2 Location | Q433R |
Mutation Type | E: escape documented in this paper |
Epitope Subtype | C |
Variant Subtype | C |
Method | Sequence |
Note | RT-YL9 mutation, YPGIKVRrL, is selected in 14% HLA-B*4202 (0% have wt YL9) subjects. The authors designate mutant YPGIKVRrL as an escape when presented by HLA-B*4202. |
Variant ID. | 3123 |
---|---|
Epitope Seq. | YPGIKVRQL |
Variant Seq. | YqGIKVRQL |
Mutations | P/Q |
Epitope Location | P2Q |
HXB2 Location | P427Q |
Mutation Type | E: escape documented in this paper |
Epitope Subtype | C |
Variant Subtype | C |
Method | Sequence |
Note | RT-YL9 mutation, YqGIKVRQ, is selected in 14% HLA-B*4202 (0% have wt YL9) subjects. The authors designate mutant YqGIKVRQ as an escape when presented by HLA-B*4202. |
Variant ID. | 3124 |
---|---|
Epitope Seq. | YPGIKVRQL |
Variant Seq. | YPkIKVRQL |
Mutations | G/K |
Epitope Location | G3K |
HXB2 Location | G428K |
Mutation Type | OV: observed variant |
Epitope Subtype | C |
Variant Subtype | C |
Method | Sequence |
Note | RT-YL9 mutation, YPkIKVRQL, is selected in 14% HLA-B*4202 (0% have wt YL9) subjects. |
Variant ID. | 3125 |
---|---|
Epitope Seq. | YPGIKVRQL |
Variant Seq. | YPGIKVsQL |
Mutations | R/S |
Epitope Location | R7S |
HXB2 Location | R432S |
Mutation Type | OV: observed variant |
Epitope Subtype | C |
Variant Subtype | C |
Method | Sequence |
Note | RT-YL9 mutation, YPGIKVsQL, is selected in 14% HLA-B*4202 (0% have wt YL9) subjects. |
Variant ID. | 3126 |
---|---|
Epitope Seq. | YPGIKVRQL |
Variant Seq. | YPGIKVkkL |
Mutations | R/K Q/K |
Epitope Location | R7K Q8K |
HXB2 Location | R432K Q433K |
Mutation Type | E: escape documented in this paper |
Epitope Subtype | C |
Variant Subtype | C |
Method | Sequence |
Note | RT-YL9 mutation, YPGIKVkkL, is selected in 14% HLA-B*4202 (0% have wt YL9) subjects. The authors designate mutant YPGIKVkkL as an escape when presented by HLA-B*4202. |
Kloverpris2012a Henrik N. Kløverpris, Mikkel Harndahl, Alasdair J. Leslie, Jonathan M. Carlson, Nasreen Ismail, Mary van der Stok, Kuan-Hsiang Gary Huang, Fabian Chen, Lynn Riddell, Dewald Steyn, Dominique Goedhals, Cloete van Vuuren, John Frater, Bruce D. Walker, Mary Carrington, Thumbi Ndung'u, Søren Buus, and Philip Goulder. HIV Control through a Single Nucleotide on the HLA-B Locus. J. Virol., 86(21):11493-11500, Nov 2012. PubMed ID: 22896606. Show all entries for this paper.
HXB2 Location | Pol(743-751) | Pol Epitope Map
View variants at this location |
|||||||
---|---|---|---|---|---|---|---|---|---|
Epitope |
LPPIVAKEI
|
Epitope Alignment | |||||||
Variants |
|
||||||||
Epitope Name | Int-LI9 | ||||||||
Species (MHC/HLA) | human(B*42:01) |
Showing all: 2 variant(s).
Variant ID. | 3117 |
---|---|
Epitope Seq. | LPPIVAKEI |
Variant Seq. | LPPxVAKEI |
Mutations | I/X |
Epitope Location | I4X |
HXB2 Location | I746X |
Mutation Type | E: escape documented in this paper |
Epitope Subtype | C |
Variant Subtype | C |
Method | Sequence |
Note | Epitope Int-LI9 carries escape mutations at position 4, LPPxVAKEI. The authors designate it an escape when presented by HLA-B*4201. |
Variant ID. | 3118 |
---|---|
Epitope Seq. | LPPIVAKEI |
Variant Seq. | LPPIVAxEI |
Mutations | K/X |
Epitope Location | K7X |
HXB2 Location | K749X |
Mutation Type | E: escape documented in this paper |
Epitope Subtype | C |
Variant Subtype | C |
Method | Sequence |
Note | Epitope Int-LI9 carries escape mutations at position 7, LPPIVAxEI. The authors designate it an escape when presented by HLA-B*4201. |
Kloverpris2012a Henrik N. Kløverpris, Mikkel Harndahl, Alasdair J. Leslie, Jonathan M. Carlson, Nasreen Ismail, Mary van der Stok, Kuan-Hsiang Gary Huang, Fabian Chen, Lynn Riddell, Dewald Steyn, Dominique Goedhals, Cloete van Vuuren, John Frater, Bruce D. Walker, Mary Carrington, Thumbi Ndung'u, Søren Buus, and Philip Goulder. HIV Control through a Single Nucleotide on the HLA-B Locus. J. Virol., 86(21):11493-11500, Nov 2012. PubMed ID: 22896606. Show all entries for this paper.
HXB2 Location | Pol(982-990) | Pol Epitope Map
View variants at this location |
||||
---|---|---|---|---|---|---|
Epitope |
IIKDYGKQM
|
Epitope Alignment | ||||
Variants |
|
|||||
Epitope Name | Int-IM9 | |||||
Species (MHC/HLA) | human(B*42:01) |
Showing all: 1 variant(s).
Variant ID. | 3116 |
---|---|
Epitope Seq. | IIKDYGKQM |
Variant Seq. | IIxDYGKQM |
Mutations | K/X |
Epitope Location | K3X |
HXB2 Location | K984X |
Mutation Type | E: escape documented in this paper |
Epitope Subtype | C |
Variant Subtype | C |
Method | CD8 T-cell Elispot - IFNy, Sequence |
Note | Novel epitope, IM9 does accumulate mutations at position 3, IIxDYGKQM. The authors designate this variant as an escape when presented by HLA-B*4201. |
Kloverpris2012a Henrik N. Kløverpris, Mikkel Harndahl, Alasdair J. Leslie, Jonathan M. Carlson, Nasreen Ismail, Mary van der Stok, Kuan-Hsiang Gary Huang, Fabian Chen, Lynn Riddell, Dewald Steyn, Dominique Goedhals, Cloete van Vuuren, John Frater, Bruce D. Walker, Mary Carrington, Thumbi Ndung'u, Søren Buus, and Philip Goulder. HIV Control through a Single Nucleotide on the HLA-B Locus. J. Virol., 86(21):11493-11500, Nov 2012. PubMed ID: 22896606. Show all entries for this paper.
HXB2 Location | Vif(48-58) | Vif Epitope Map
View variants at this location |
||||
---|---|---|---|---|---|---|
Epitope |
HPKVSSEVHIA
|
Epitope Alignment | ||||
Variants |
|
|||||
Epitope Name | Vif-HI10 | |||||
Species (MHC/HLA) | human(B*42:01) |
Showing all: 1 variant(s).
Variant ID. | 3115 |
---|---|
Epitope Seq. | HPKVSSEVHIa |
Variant Seq. | xPKVSSEVHIa |
Mutations | H/X |
Epitope Location | H1X |
HXB2 Location | H48X |
Mutation Type | E: escape documented in this paper |
Epitope Subtype | C |
Variant Subtype | C |
Method | CD8 T-cell Elispot - IFNy, Sequence |
Note | Mutations at position 1, xPKVSSEVHIa, were detected. The authors designate this variant as an escape when presented by HLA-B*4201. |
Kloverpris2012a Henrik N. Kløverpris, Mikkel Harndahl, Alasdair J. Leslie, Jonathan M. Carlson, Nasreen Ismail, Mary van der Stok, Kuan-Hsiang Gary Huang, Fabian Chen, Lynn Riddell, Dewald Steyn, Dominique Goedhals, Cloete van Vuuren, John Frater, Bruce D. Walker, Mary Carrington, Thumbi Ndung'u, Søren Buus, and Philip Goulder. HIV Control through a Single Nucleotide on the HLA-B Locus. J. Virol., 86(21):11493-11500, Nov 2012. PubMed ID: 22896606. Show all entries for this paper.
HXB2 Location | Vpr(34-42) | Vpr Epitope Map
View variants at this location |
||||
---|---|---|---|---|---|---|
Epitope |
FPRPWLHGL
|
Epitope Alignment | ||||
Variants |
|
|||||
Epitope Name | Vpr-FL9 | |||||
Species (MHC/HLA) | human(B*42:01, B*42:02) |
Showing all: 1 variant(s).
Variant ID. | 3114 |
---|---|
Epitope Seq. | FPRPWLHGL |
Variant Seq. | FPRPWLHxL |
Mutations | G/X |
Epitope Location | G8X |
HXB2 Location | G41X |
Mutation Type | E: escape documented in this paper |
Epitope Subtype | C |
Variant Subtype | C |
Method | CD8 T-cell Elispot - IFNy, Sequence |
Note | Mutations at position 8 in Vpr-FL9, FPRPWLHxL, were detected, but only for HLA-B*4201-positive subjects (75% of B*4201 subjects). The authors designate this variant as an escape when presented by HLA-B*4201. |
Kloverpris2012a Henrik N. Kløverpris, Mikkel Harndahl, Alasdair J. Leslie, Jonathan M. Carlson, Nasreen Ismail, Mary van der Stok, Kuan-Hsiang Gary Huang, Fabian Chen, Lynn Riddell, Dewald Steyn, Dominique Goedhals, Cloete van Vuuren, John Frater, Bruce D. Walker, Mary Carrington, Thumbi Ndung'u, Søren Buus, and Philip Goulder. HIV Control through a Single Nucleotide on the HLA-B Locus. J. Virol., 86(21):11493-11500, Nov 2012. PubMed ID: 22896606. Show all entries for this paper.